Trends in the non‐steroidal anti‐inflammatory drug market in six Central–Eastern European countries based on retail information
Pharmacoepidemiology and Drug Safety2009Vol. 19(2), pp. 183–190
Citations Over TimeTop 10% of 2009 papers
Abstract
Differences in the six countries concerning their NSAID consumption and market trends could not be explained with the inequalities in patient characteristics. The conventional NSAID retail gave the majority of the total NSAID market. The consumption of selective COX2 inhibitors in all of the six countries were much lower than in the US or Australia. The NSAID risk profile in the region is comparable to previous studies in other countries.
Related Papers
- Nimesulide and meloxicam are a safe alternative drugs for patients intolerant to nonsteroidal anti-inflammatory drugs.(2003)
- → UV-Spectrophotometric Determination of the Active Pharmaceutical Ingredients Meloxicam and Nimesulide in Cleaning Validation Samples with Sodium Carbonate(2023)3 cited
- Safety of nimesulide, meloxicam and rofecoxib as alternative analgesics.(2001)
- → Anti-inflammatory activity of topical nimesulide gel in various experimental models(1996)18 cited
- → Beneficial interaction of nimesulide with NSAIDs(2007)4 cited